De novo urethral stricture disease in renal transplant recipients

Authors

  • Julie Wong 1. Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada
  • Sarah Keyes 2. Department of Medicine, University of British Columbia, Vancouver, BC, Canada
  • David Harriman 1. Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada
  • Christopher Nguan 1. Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada 2. Department of Medicine, University of British Columbia, Vancouver, BC, Canada

DOI:

https://doi.org/10.5489/cuaj.8296

Keywords:

urethral stricture, renal transplant, lower urinary tract symptoms, urinary tract infection, delayed graft function

Abstract

INTRODUCTION: With routine catheterization and low urine output pre-transplant, renal transplant recipients (RTRs) may be at risk of urethral stricture disease post-transplant. The objective of this study was to characterize new urethral stricture disease in males following renal transplant.

METHODS: A retrospective chart review was carried out on all male RTRs at Vancouver General Hospital who developed urethral strictures from October 2009–2019. Descriptive analyses were conducted on patient characteristics. Comparative analyses against non-stricture RTRs were carried out.

RESULTS: Of 636 RTRs, 18 (2.8%) developed a postoperative urethral stricture. Median time from transplant to stricture discovery was 56 days (range 8–618 days). One-third of stricture patients had prior risk factors for stricture formation. Post-transplant, 77.8% presented symptomatically, with 61.1% requiring intervention. Overall graft survival rate was 88.9% among the RTR stricture group; 16.7% experienced acute rejection and 22.2% had delayed graft function (DGF). There was no significant association between developing postoperative urethral stricture and urinary tract infection (Chi-squared [X2]=0.04, p=0.84; odds ratio [OR] 0.81, 95% confidence interval [CI] 0.1–6.21), DGF (X2=0.14, p=0.70; OR 0.8, CI 0.26–2.48), or acute rejection (X2=2.02, p=0.14; OR 2.55, CI 0.71–9.12).

CONCLUSIONS: De novo post-transplant urethral stricture rates appear to occur at a higher rate than the general population and contribute to patient morbidity. Stricture disease should be considered post-transplantation in patients with voiding dysfunction, even if they don’t have prior risk factors. Multicenter studies should be considered to elucidate any relationship between urethral stricture and graft survival.

Downloads

Download data is not yet available.

Downloads

Published

2023-07-21

How to Cite

Wong, J., Keyes, S., Harriman, D., & Nguan, C. (2023). De novo urethral stricture disease in renal transplant recipients. Canadian Urological Association Journal, 17(10), 346–52. https://doi.org/10.5489/cuaj.8296

Issue

Vol. 17 No. 10 (2023): CUAJ October

Section

Original Research

License

You, the Author(s), assign your copyright in and to the Article to the Canadian Urological Association. This means that you may not, without the prior written permission of the CUA:

  • Post the Article on any Web site
  • Translate or authorize a translation of the Article
  • Copy or otherwise reproduce the Article, in any format, beyond what is permitted under Canadian copyright law, or authorize others to do so
  • Copy or otherwise reproduce portions of the Article, including tables and figures, beyond what is permitted under Canadian copyright law, or authorize others to do so.

The CUA encourages use for non-commercial educational purposes and will not unreasonably deny any such permission request.

You retain your moral rights in and to the Article. This means that the CUA may not assert its copyright in such a way that would negatively reflect on your reputation or your right to be associated with the Article.

The CUA also requires you to warrant the following:

  • That you are the Author(s) and sole owner(s), that the Article is original and unpublished and that you have not previously assigned copyright or granted a licence to any other third party;
  • That all individuals who have made a substantive contribution to the article are acknowledged;
  • That the Article does not infringe any proprietary right of any third party and that you have received the permissions necessary to include the work of others in the Article; and
  • That the Article does not libel or violate the privacy rights of any third party.